Abstracts of the 2nd COST B22 Congress on Drug Discovery and Development for Parasitic Diseases, Siena, Italy, 29 September-1 October 2005
- PMID: 16252442
Abstracts of the 2nd COST B22 Congress on Drug Discovery and Development for Parasitic Diseases, Siena, Italy, 29 September-1 October 2005
Similar articles
-
Target assessment for antiparasitic drug discovery.Trends Parasitol. 2007 Dec;23(12):589-95. doi: 10.1016/j.pt.2007.08.019. Epub 2007 Oct 24. Trends Parasitol. 2007. PMID: 17962072 Free PMC article. Review.
-
Current antiparasitic drug targets and a paradigm shift in discovery of new antiparasitic drugs and vaccines.Curr Drug Targets. 2008 Nov;9(11):921. doi: 10.2174/138945008786786145. Curr Drug Targets. 2008. PMID: 18991603 No abstract available.
-
Drug resistance in parasites: can we stay ahead of the evolutionary curve?Trends Parasitol. 2003 Nov;19(11):532-7. doi: 10.1016/j.pt.2003.09.009. Trends Parasitol. 2003. PMID: 14580966 Review. No abstract available.
-
Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.Curr Drug Metab. 2016;17(10):937-970. doi: 10.2174/1389200217666161004143152. Curr Drug Metab. 2016. PMID: 27719626 Review.
-
Moving targets: parasites, resistance and access to drugs. Proceedings of a colloquium. Antwerp, 4-6 December 2000.Trop Med Int Health. 2001 Nov;6(11):843-964. Trop Med Int Health. 2001. PMID: 11794243 No abstract available.